Actinium Pharmaceuticals, Inc. (Delaware)Actinium Pharmaceuticals, Inc. (Delaware)Actinium Pharmaceuticals, Inc. (Delaware)

Actinium Pharmaceuticals, Inc. (Delaware)

No trades
See on Supercharts

Price target

5.750.000.00%
The 4 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.

Analyst rating

Based on 4 analysts giving stock ratings in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


In the next quarter Actinium Pharmaceuticals, Inc. (Delaware) revenue is expected to reach 0.00 USD. Check out Actinium Pharmaceuticals, Inc. (Delaware) revenue and earnings and make informed decisions.
According to analysts, ATNM price target is 5.75 USD with a max estimate of 9.00 USD and a min estimate of 4.00 USD. Check if this forecast comes true in a year, meanwhile watch Actinium Pharmaceuticals, Inc. (Delaware) stock price chart and keep track of the current situation with ATNM news and stock market news.